QNTM
NASDAQ · Pharmaceuticals
Quantum Biopharma-B Sub Vot
$3.85
+0.19 (+5.19%)
Open$3.50
Previous Close$3.66
Day High$4.06
Day Low$3.50
52W High$52.00
52W Low$2.85
Volume—
Avg Volume14.0K
Market Cap34.74M
P/E Ratio—
EPS$-8.27
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+146.2% upside
Current
$3.85
$3.85
Target
$9.48
$9.48
$6.03
$9.48 avg
$10.62
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 16.44M | 7.61M | 6.92M |
| Net Income | -72,835,758 | 1.84M | 1.19M |
| Profit Margin | -19,353.5% | 24.2% | 17.2% |
| EBITDA | -45,088,498 | 2.64M | 2.30M |
| Free Cash Flow | — | 1.03M | 1.07M |
| Rev Growth | — | +16.6% | +5.5% |
| Debt/Equity | 0.02 | 0.64 | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |